Literature DB >> 19505799

Two-day treatment of auditory hallucinations by high frequency rTMS guided by cerebral imaging: a 6 month follow-up pilot study.

A Montagne-Larmurier1, O Etard, A Razafimandimby, R Morello, S Dollfus.   

Abstract

BACKGROUND: Recently, repetitive Transcranial Magnetic Stimulation (rTMS) has been introduced as an alternative treatment for auditory hallucinations in schizophrenic patients that fail to respond to antipsychotics. Until now, application of rTMS has been at low frequency, and most commonly applied to the left temporoparietal cortex. This 6-month follow-up pilot study was performed to demonstrate the efficacy of high frequency rTMS guided by anatomical and functional Magnetic Resonance Imaging (MRI).
METHODS: Eleven patients with schizophrenia (DSM-IV) were treated with high frequency (20 Hz) rTMS delivered over 2 days; they were then followed for 6 months. The target area was identified by fMRI as the highest activation cluster along the posterior part of the left superior temporal sulcus from the BOLD signal of each subject during a language task.
RESULTS: A significant reduction in global severity and frequency of auditory hallucinations between baseline and post-treatment day 12 was observed. Auditory hallucinations were entirely relieved at 6-month follow-up in 2 patients. The treatment was well tolerated in all patients.
CONCLUSIONS: This is the first study reporting successful treatment of auditory hallucinations with 20 Hz rTMS. The efficacy at short term, the strength of the clinical response, the persistence of therapeutic effect over a 6-month follow-up, the safety profile, and the short duration of treatment present a considerable therapeutic gain compared to low frequency rTMS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19505799     DOI: 10.1016/j.schres.2009.05.006

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  20 in total

Review 1.  Noninvasive brain stimulation in Alzheimer's disease: systematic review and perspectives for the future.

Authors:  Catarina Freitas; Helena Mondragón-Llorca; Alvaro Pascual-Leone
Journal:  Exp Gerontol       Date:  2011-04-14       Impact factor: 4.032

Review 2.  The treatment of hallucinations in schizophrenia spectrum disorders.

Authors:  Iris E C Sommer; Christina W Slotema; Zafiris J Daskalakis; Eske M Derks; Jan Dirk Blom; Mark van der Gaag
Journal:  Schizophr Bull       Date:  2012-02-24       Impact factor: 9.306

Review 3.  Synaptic plasticity in neurodegenerative diseases evaluated and modulated by in vivo neurophysiological techniques.

Authors:  F Pilato; P Profice; F Ranieri; F Capone; R Di Iorio; L Florio; V Di Lazzaro
Journal:  Mol Neurobiol       Date:  2012-07-22       Impact factor: 5.590

4.  Treatment of auditory verbal hallucinations with transcranial magnetic stimulation in a patient with psychotic major depression: one-year follow-up.

Authors:  Catarina Freitas; Chester Pearlman; Alvaro Pascual-Leone
Journal:  Neurocase       Date:  2011-06-28       Impact factor: 0.881

5.  Repetitive transcranial magnetic stimulation (rTMS) in schizophrenia with treatment-refractory auditory hallucinations and major self-mutilation.

Authors:  Torsten Schulz; Christoph Berger; Beate Krecklow; Jens Kurth; Sarah Schwarzenboeck; Paul Foley; Johannes Thome; Bernd Joachim Krause; Jacqueline Hoeppner
Journal:  J Neural Transm (Vienna)       Date:  2014-01-08       Impact factor: 3.575

6.  Transcranial magnetic stimulation of Wernicke's and Right homologous sites to curtail "voices": a randomized trial.

Authors:  Ralph E Hoffman; Kun Wu; Brian Pittman; John D Cahill; Keith A Hawkins; Thomas Fernandez; Jonas Hannestad
Journal:  Biol Psychiatry       Date:  2013-02-26       Impact factor: 13.382

7.  Theta Burst Transcranial Magnetic Stimulation for Auditory Verbal Hallucinations: Negative Findings From a Double-Blind-Randomized Trial.

Authors:  Sanne Koops; Edwin van Dellen; Maya J L Schutte; Wendy Nieuwdorp; Sebastiaan F W Neggers; Iris E C Sommer
Journal:  Schizophr Bull       Date:  2015-07-28       Impact factor: 9.306

8.  Individualized rTMS neuronavigated according to regional brain metabolism ((18)FGD PET) has better treatment effects on auditory hallucinations than standard positioning of rTMS: a double-blind, sham-controlled study.

Authors:  Monika Klirova; Jiri Horacek; Tomas Novak; Jan Cermak; Filip Spaniel; Lucie Skrdlantova; Pavel Mohr; Cyril Höschl
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-09-15       Impact factor: 5.270

9.  Cognitive Enhancing Effect of High-Frequency Neuronavigated rTMS in Chronic Schizophrenia Patients With Predominant Negative Symptoms: A Double-Blind Controlled 32-Week Follow-up Study.

Authors:  Mei Hong Xiu; Heng Yong Guan; Jian Min Zhao; Ke Qiang Wang; Yan Fen Pan; Xiu Ru Su; Yu Hong Wang; Jin Ming Guo; Long Jiang; Hong Yu Liu; Shi Guang Sun; Hao Ran Wu; Han Song Geng; Xiao Wen Liu; Hui Jing Yu; Bao Chun Wei; Xi Po Li; Tammy Trinh; Shu Ping Tan; Xiang Yang Zhang
Journal:  Schizophr Bull       Date:  2020-03-17       Impact factor: 9.306

10.  High-Frequency Neuronavigated rTMS in Auditory Verbal Hallucinations: A Pilot Double-Blind Controlled Study in Patients With Schizophrenia.

Authors:  Sonia Dollfus; Nemat Jaafari; Olivier Guillin; Benoit Trojak; Marion Plaze; Ghassen Saba; Cécilia Nauczyciel; Aurélie Montagne Larmurier; Nathalie Chastan; Vincent Meille; Marie-Odile Krebs; Samar S Ayache; Jean Pascal Lefaucheur; Annick Razafimandimby; Elise Leroux; Rémy Morello; Jean Marie Batail; Perrine Brazo; Nicolas Lafay; Issa Wassouf; Ghina Harika-Germaneau; Remy Guillevin; Carole Guillevin; Emmanuel Gerardin; Maud Rotharmel; Benoit Crépon; Raphael Gaillard; Christophe Delmas; Gael Fouldrin; Guillaume Laurent; Clément Nathou; Olivier Etard
Journal:  Schizophr Bull       Date:  2018-04-06       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.